Correlation Between Pfizer and Goldman Sachs
Can any of the company-specific risk be diversified away by investing in both Pfizer and Goldman Sachs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Goldman Sachs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Goldman Sachs Mlp, you can compare the effects of market volatilities on Pfizer and Goldman Sachs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Goldman Sachs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Goldman Sachs.
Diversification Opportunities for Pfizer and Goldman Sachs
-0.84 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Pfizer and Goldman is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Goldman Sachs Mlp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Goldman Sachs Mlp and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Goldman Sachs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Goldman Sachs Mlp has no effect on the direction of Pfizer i.e., Pfizer and Goldman Sachs go up and down completely randomly.
Pair Corralation between Pfizer and Goldman Sachs
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Goldman Sachs. In addition to that, Pfizer is 1.93 times more volatile than Goldman Sachs Mlp. It trades about -0.03 of its total potential returns per unit of risk. Goldman Sachs Mlp is currently generating about 0.15 per unit of volatility. If you would invest 2,667 in Goldman Sachs Mlp on August 29, 2024 and sell it today you would earn a total of 1,121 from holding Goldman Sachs Mlp or generate 42.03% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pfizer Inc vs. Goldman Sachs Mlp
Performance |
| Timeline |
| Pfizer Inc |
| Goldman Sachs Mlp |
Pfizer and Goldman Sachs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and Goldman Sachs
The main advantage of trading using opposite Pfizer and Goldman Sachs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Goldman Sachs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Goldman Sachs will offset losses from the drop in Goldman Sachs' long position.| Pfizer vs. Pharvaris BV | Pfizer vs. Brinker International | Pfizer vs. Alcoa Corp | Pfizer vs. Direxion Daily FTSE |
| Goldman Sachs vs. HUMANA INC | Goldman Sachs vs. Aquagold International | Goldman Sachs vs. Barloworld Ltd ADR | Goldman Sachs vs. Morningstar Unconstrained Allocation |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |